3,632
edits
TYK87: Difference between revisions
no edit summary
m (1 revision imported) |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
All of the following are known effects of NITROUS OXIDE administration EXCEPT: | All of the following are known effects of NITROUS OXIDE administration EXCEPT: | ||
| Line 13: | Line 12: | ||
E. Minimal (non-clinically significant) increase in PVR in patients with normal PVR at baseline | E. Minimal (non-clinically significant) increase in PVR in patients with normal PVR at baseline | ||
<div class="mw-customtoggle-TYK_Answer" style="text-align: right; color:#0000ff">Click for Answer</div> | |||
<div class="mw-collapsible mw-collapsed" id="mw-customcollapsible-TYK_Answer"> | |||
<div class="mw-collapsible- | |||
==Answer== | ==Answer== | ||
The answer is D. | The answer is D. | ||
| Line 29: | Line 26: | ||
This, however, may not quite be the case in pediatrics. A study in children with CHD and mild to moderately elevated PVR did not show an increase in shunting or PVRI. However, they did show a decrease in systemic hemodynamics similar to adult studies. | This, however, may not quite be the case in pediatrics. A study in children with CHD and mild to moderately elevated PVR did not show an increase in shunting or PVRI. However, they did show a decrease in systemic hemodynamics similar to adult studies. | ||
==Notes== | ==Notes== | ||
<references /> | <references /> | ||
==Keywords== | ==Keywords== | ||
</div> | </div> | ||
---- | ---- | ||
---- | ---- | ||